Articles » 2008 » May 2008 » Feature


Welcome to our 4th Annual Contract Pharma Outsourcing Survey! More than 175 sponsor-side respondents offered up their opinions on outsourcing trends for this year's poll. Here's a breakdown of respondents by company type:

  • Small/Mid-Tier Pharma - 25.7%
  • Big Pharma - 23.6%
  • Virtual Pharma - 12.1%
  • Generic Pharma - 12.1%
  • Emerging Biopharma - 10.0%
  • Specialty Pharma - 5.7%
  • Big Bio - 3.6%
  • Other - 7.1%

Slow & Steady?



Last year, 22% of total respondents believed that they'd spend the same or less on outsourcing in the coming year; this year, that number dropped to 16%. Last year, 30% of respondents reported they'd increase outsourcing spending by 10% or more in the coming year; that number dropped to 23% this time around.

The percentage of respondents who believe that their outsourcing expenditure will increase from 1-5% from the previous year nearly doubled, from 17% in the previous survey to 32% this time around. The portion who will increase outsourcing spending from 6-10% in the coming year was nearly steady, dropping from 32% to 29%.

For a PDF of this year's Outsourcing Survey, including information on spending growth, preferred vendors, sponsor attitudes, and outsourcing to Asia, just click here!

(Looking for the 2007 edition? click here)

--Gil Y. Roth
Editor
Contract Pharma

PS: Thanks to all who took the time to respond to this year's Outsourcing Survey. The winner of our 80gb iPod Classic drawing is Syed Yousuf of Pfizer! Congratulations!